Stem cell based therapy is considered promising for the treatment of MS using autologous Mesenchymal Stem Cells (MSCs); the major mechanism of action of MSCs therapy is to inhibit various components of the immune system that contribute to tissue damage. MSCs can access the CNS where they can provide protection against tissue damage and may facilitate tissue regeneration.
Assess the safety of injecting auotologous MSCs to MS
patients who fail to respond to conventional treatment.
Assess the therapeutic benefits on MS patients after
The project has been
running for the last 3 years and hasbeen completed. Preliminary analysis showed disease stability and
encouraging results with good safety. The project is supported by the
University of Jordan. We are preparing to initiated a second different source of stem cells and recruiting more patients
For more details please visit the link: